Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
To determine the prevalence and the 3-months incidence of SARS-CoV-2 in cancer patients (Part
A).
To evaluate the Covid-19 disease-specific mortality rate in cancer patients treated by
hydroxychloroquine and azithromycin (Part B).